BSE LTP 2724. ENTRY PRICE 2477. TARGET 2628, SL 2453.

Jun 13, 2025 - 23:00
 0  3
BSE LTP 2724. ENTRY PRICE 2477. TARGET 2628, SL 2453.

BSE LTP 2724. ENTRY PRICE 2477. TARGET 2628, SL 2453.

The stock is in corrective mode after making a high of Rs.3030. The stock has a good support at around 2477-2470 level with a stop loss below 2453-2450. The upside could be measured at around Rs.2628.

BSE stock price declined sharply over two consecutive sessions, falling a combined 7.3% as of Thursday, after the stock was placed under the Additional Surveillance Measure (ASM) framework by the National Stock Exchange. The regulatory action has triggered profit-taking and heightened investor caution.

BSE was placed under the ASM framework on Wednesday—a move that typically signals increased regulatory oversight due to sharp price movements or unusual trading volumes. The ASM framework, designed to maintain market integrity, entails heightened monitoring, higher margin requirements, and possible restrictions on intraday trading.

BSE is currently trading at a stretched valuation, with a projected FY27E price-to-earnings (P/E) multiple of 35.1x—significantly higher than sector averages. Analysts at Arihant Capital believe such valuations are unjustified given the company’s reliance on external factors and exposure to market volatility.

Despite strong financial performance in FY25, BSE Ltd.’s reliance on volatile trading volumes, high settlement costs, and stretched valuations make it a risky investment at current levels. The company’s growth prospects are overshadowed by macroeconomic uncertainties and competitive pressures.

Company profile :

The Bombay Stock Exchange (BSE) is India’s oldest and one of the most significant stock exchanges in Asia, with a legacy that dates back to 1875. Founded as "The Native Share & Stock Brokers’ Association," BSE has played a pivotal role in the development of India’s capital markets, evolving from a gathering under a banyan tree in Mumbai to a globally recognized financial institution.

Key Businesses and Offerings

  • Equity and Derivatives Trading: Enabling buying and selling of securities with advanced speed and efficiency.
  • Debt Instruments: Providing a platform for trading in government and corporate bonds.
  • Mutual Funds Distribution: Through its subsidiary BSE StAR MF, it is India’s largest online mutual fund platform.
  • SME and Startup Listings: BSE was the first exchange in India to launch a dedicated SME platform, supporting small and medium enterprises and startups with access to capital markets.
  • Commodities Segment: Though primarily known for equities, BSE has diversified into commodities through BSE e-Agricultural Markets and BSE EDELWEISS Commodity Exchange.

As of 2025, BSE ranks among the top 10 global exchanges by number of listed companies (over 5,800) and is one of the fastest-growing exchanges in terms of IPOs and SME listings. Its revenue sources include transaction charges, annual listing fees, data dissemination, technology services, and clearing income. BSE has seen strong financial growth over recent years. The rally in equity markets, increasing retail participation, and a surge in IPOs have boosted trading volumes and revenue.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
ASJ_Stockmarketclasses I’m Prasad Bhave, a Senior Research Analyst with over 15 years of experience in market intelligence, data-driven strategy, and trend forecasting. I specialize in translating complex data into actionable insights that support business growth and decision-making. My work spans across sectors including Finance / FMCG / Technology / Healthcare, where I’ve led high-impact research projects, competitor analysis, and strategic reports for C-level stakeholders. I’m passionate about combining deep research with practical outcomes, and thrive in environments that demand both analytical rigor and creative thinking. Whether it's uncovering hidden market opportunities or refining business strategies, I aim to deliver clarity and results through data.